naftopidil has been researched along with Hypermyotonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, SA | 1 |
| Akino, H; Aoki, Y; Matsuta, Y; Miwa, Y; Oyama, N; Tanase, K; Yokoyama, O; Yusup, A | 1 |
1 trial(s) available for naftopidil and Hypermyotonia
| Article | Year |
|---|---|
Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Ethamsylate; Humans; Male; Muscle Hypertonia; Naphthalenes; Phytotherapy; Piperazines; Plant Extracts; Prostatic Hyperplasia; Single-Blind Method; Treatment Outcome; Urinary Bladder Neck Obstruction; Urodynamics | 2005 |
1 other study(ies) available for naftopidil and Hypermyotonia
| Article | Year |
|---|---|
Improvement of bladder storage function by alpha1-blocker depends on the suppression of C-fiber afferent activity in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Diterpenes; Dose-Response Relationship, Drug; Female; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Muscle Hypertonia; Naphthalenes; Nerve Fibers, Unmyelinated; Neurons, Afferent; Neurotoxins; Piperazines; Rats; Rats, Sprague-Dawley; Urinary Bladder | 2006 |